Non-surgical, localized delivery of compositions for placental growth factors
View Patent ↗Described herewith are compositions comprising placental growth factors and methods for non-surgical, localized delivery thereof. The composition is delivered to a diseased or injured organ and/or body part and is formulated in a manner which allows for localized retention of the composition at the site of delivery.
1. A composition comprising a sufficient amount of placental growth factors to treat a diseased or injured organ or body part wherein said composition is in the form of a localized bioerodible mass when applied to or proximate to said diseased or injured organ or body part, wherein said composition further comprises micronized placental tissue particles capable of being filtered through a sieve having a pore size from about 500 μm to about 10 μm.
2. The composition of claim 1 , further comprising a localization agent.
3. The composition of claim 2 , wherein the localization agent is a thixotropic agent, or a phase changing agent.
4. The composition of claim 3 , wherein the thixotropic agent is selected from the group consisting of hyaluronic acid, collagen, thrombin gels, fibrin gels and fibrin glues.
5. The composition of claim 3 , wherein the phase changing agent is a gel forming agent.
6. The composition of claim 5 , wherein the gel forming agent is a copolymer or tripolymer of oxyethylene and oxypropylene units.
7. The composition of claim 2 , wherein the localization agent is selected from the group consisting of a hydrogel, a polymer, and a collagen gel.
8. The composition of claim 1 , wherein the micronized placental tissue particles are capable of being filtered through a sieve having a pore size from about 300 μm to about 10 μm.
9. The composition of claim 1 , wherein the micronized placental tissue particles are capable of being filtered through a sieve having a pore size from about 250 μm to about 25 μm.
10. A method for preparing a composition for localized delivery of placental growth factors, comprising combining an aqueous suspension of micronized placental tissue particles, the micronized placental tissue particles are capable of being filtered through a sieve having a pore size from about 500 μm to about 10 μm, an aqueous solution of placental growth factors, and a sufficient amount of a localization agent, whereby the composition is locally retained at the site of delivery upon administration.